DotLab™ is solving some of the world's most difficult diagnostic challenges head-on via the latest advancements in multiomics and computational biology delivering clinical innovations to areas of significant unmet need. Initially, the company is harnessing its expertise with novel, cutting-edge biomarkers and the power of machine learning to deliver the first non-invasive tool to diagnose endometriosis, resulting in a paradigm shift in the identification and management of the disease. DotLab will also pioneer data-driven management of women's health diseases through the collection of real-world, longitudinal data across multiple timepoints.